Evidence map›Paper›PMID 40361140›Full record

ArticleBiomedical engineering online2025

Preparation and characterization of human decellularized ovarian scaffold based on supercritical carbon dioxide protocol.

Fatemeh Hosseinpour, Ali Zeinolabedini Hezave, Tahereh Talaei-Khozani, Mojtaba Rastgou-Maeini, Ashraf Hassanpour-Dehnavi

Abstract read
In one paragraph

Article in Biomedical engineering online, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fatemeh HosseinpourTissue Engineering Lab., Anatomy Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Ali Zeinolabedini HezaveFanavari Atiyeh Pouyandegan Exir Company (APEX Technologies Co.), Science and Technology Park, Arak, Iran.
Tahereh Talaei-KhozaniTissue Engineering Lab., Anatomy Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mojtaba Rastgou-MaeiniTissue Engineering Lab., Anatomy Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Ashraf Hassanpour-DehnaviTissue Engineering Lab., Anatomy Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. a_hassanpour@sums.ac.ir.

Funding

Vice-Chancellor of Research in Shiraz University of Medical Sciences 26467
6 · The paper itself

Abstract

backgroundPrimary ovarian insufficiency affecting 1-3% of women under 40, causes premature menopause and estrogen deficiency. With increasing life expectancy, a large percentage of women also face estrogen-related symptoms. A bioengineered ovary is one of the strategies to replace or enhance ovarian tissue function. A key advancement in bioengineering is the development of ovarian decellularized extracellular matrix scaffolds that mimic natural ovarian niche. Recent studies indicate that supercritical carbon dioxide (scCo

methodsWe evaluated two distinct pressure conditions (200 and 300 bar), while maintaining identical thermal (40 °C) and temporal (1.5 h) parameters, during the scCO

resultsApplication of 1% SDS, while utilizing the scCO

conclusionsWe propose an optimal protocol utilizing 1% SDS as a pretreatment, followed by the scCO

Indexed as

Carbon DioxideDecellularized Extracellular MatrixOvaryTissue ScaffoldsCell SurvivalExtracellular MatrixFemaleGlycosaminoglycansHumansPressureTissue EngineeringCarbon DioxideDecellularized Extracellular MatrixGlycosaminoglycansDecellularizationECM-based scaffoldsOvaryscCO2Tissue engineering

Identifiers

PMID40361140
PMCPMC12070545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.